Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Patterson

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Pharmacogenomics|December 15, 2010
Designing pharmacogenomic studies to be fit for purposeDaniel K Burns, Arlene R Hughes, Aidan Power, et al.
Molecular Biology of the Cell|June 1, 2004
Proteomic analysis of interchromatin granule clustersNoriko Saitoh, Chris S Spahr, Scott D Patterson, et al.
Journal of the American Society for Mass Spectrometry|March 5, 2004
Quantitation of phosphopeptides using affinity chromatography and stable isotope labelingTao He, Kim Alving, Brian Feild, et al.
Cancers|October 14, 2022
Defining A Liquid Biopsy Profile of Circulating Tumor Cells and Oncosomes in Metastatic Colorectal Cancer for Clinical UtilitySachin Narayan, George Courcoubetis, Jeremy Mason, et al.
Virchows Archiv : an International Journal of Pathology|November 18, 2015
RAS testing in metastatic colorectal cancer: advances in EuropeJ Han J M Van Krieken, Etienne Rouleau, Marjolijn J L Ligtenberg, et al.
Advances in Anatomic Pathology|February 6, 2016
The State of the Art in Colorectal Cancer Molecular Biomarker TestingRaju K Pillai, Jean R Lopategui, Deepti Dhall, et al.
Clinical Chemistry|November 8, 2014
Biomarkers in the pharmaceutical industryOmar F Laterza, Andrew Plump, Jeffrey E Ming, et al.
Plos One|March 26, 2015
Functional EpoR pathway utilization is not detected in primary tumor cells isolated from human breast, non-small cell lung, colorectal, and ovarian tumor tissuesScott D Patterson, John M Rossi, Katherine L Paweletz, et al.
Plos One|October 26, 2023
RNA-seq RNAaccess identified as the preferred method for gene expression analysis of low quality FFPE samplesKai Song, Emon Elboudwarej, Xi Zhao, et al.
Diagnostic Pathology|April 20, 2010
A comparability study of 5 commercial KRAS testsKelly Oliner, Todd Juan, Sid Suggs, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Pharmacogenomics|December 15, 2010
Designing pharmacogenomic studies to be fit for purposeDaniel K Burns, Arlene R Hughes, Aidan Power, et al.
Molecular Biology of the Cell|June 1, 2004
Proteomic analysis of interchromatin granule clustersNoriko Saitoh, Chris S Spahr, Scott D Patterson, et al.
Journal of the American Society for Mass Spectrometry|March 5, 2004
Quantitation of phosphopeptides using affinity chromatography and stable isotope labelingTao He, Kim Alving, Brian Feild, et al.
Cancers|October 14, 2022
Defining A Liquid Biopsy Profile of Circulating Tumor Cells and Oncosomes in Metastatic Colorectal Cancer for Clinical UtilitySachin Narayan, George Courcoubetis, Jeremy Mason, et al.
Virchows Archiv : an International Journal of Pathology|November 18, 2015
RAS testing in metastatic colorectal cancer: advances in EuropeJ Han J M Van Krieken, Etienne Rouleau, Marjolijn J L Ligtenberg, et al.
Advances in Anatomic Pathology|February 6, 2016
The State of the Art in Colorectal Cancer Molecular Biomarker TestingRaju K Pillai, Jean R Lopategui, Deepti Dhall, et al.
Clinical Chemistry|November 8, 2014
Biomarkers in the pharmaceutical industryOmar F Laterza, Andrew Plump, Jeffrey E Ming, et al.
Plos One|March 26, 2015
Functional EpoR pathway utilization is not detected in primary tumor cells isolated from human breast, non-small cell lung, colorectal, and ovarian tumor tissuesScott D Patterson, John M Rossi, Katherine L Paweletz, et al.
Plos One|October 26, 2023
RNA-seq RNAaccess identified as the preferred method for gene expression analysis of low quality FFPE samplesKai Song, Emon Elboudwarej, Xi Zhao, et al.
Diagnostic Pathology|April 20, 2010
A comparability study of 5 commercial KRAS testsKelly Oliner, Todd Juan, Sid Suggs, et al.
Pageof 6